Verastem (VSTM) Change in Accured Expenses: 2018-2025

Historic Change in Accured Expenses for Verastem (VSTM) over the last 7 years, with Sep 2025 value amounting to $15.0 million.

  • Verastem's Change in Accured Expenses rose 202.54% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year increase of 697.24%. This contributed to the annual value of $8.0 million for FY2024, which is 172.26% up from last year.
  • According to the latest figures from Q3 2025, Verastem's Change in Accured Expenses is $15.0 million, which was up 277.17% from $4.0 million recorded in Q2 2025.
  • Verastem's 5-year Change in Accured Expenses high stood at $15.0 million for Q3 2025, and its period low was -$5.0 million during Q1 2021.
  • Moreover, its 3-year median value for Change in Accured Expenses was $3.2 million (2024), whereas its average is $3.6 million.
  • In the last 5 years, Verastem's Change in Accured Expenses plummeted by 300.16% in 2021 and then spiked by 2,285.16% in 2025.
  • Verastem's Change in Accured Expenses (Quarterly) stood at $3.4 million in 2021, then plummeted by 94.28% to $195,000 in 2022, then soared by 57.33% to -$1.0 million in 2023, then skyrocketed by 47.94% to $3.8 million in 2024, then spiked by 202.54% to $15.0 million in 2025.
  • Its Change in Accured Expenses was $15.0 million in Q3 2025, compared to $4.0 million in Q2 2025 and $2.7 million in Q1 2025.